Effects of flecainide and quinidine on human atrial action potentials : role of rate-dependence and comparison with guinea pig, rabbit, and dog tissues

作者: ZG Wang , L Conrad Pelletier , Mario Talajic , Stanley Nattel , None

DOI: 10.1161/01.CIR.82.1.274

关键词:

摘要: Flecainide and other class IC antiarrhythmic drugs are effective in the prevention termination of atrial fibrillation, but mechanism this action is unknown. To gain insights into potential cellular mechanisms, we evaluated response human potentials to equimolar therapeutic concentrations flecainide quinidine compared that guinea pig, rabbit, dog atria. Both compounds reduced Vmax more as activation rate increased, was potent than had slower kinetics. The rate-dependence reduction similar for all species, tissue sensitive tested. In contrast changes Vmax, drug-induced alterations duration showed opposite two drugs. Quinidine increased 95% repolarization (APD95) atria by 33 +/- 7% (mean SD) at a cycle length 1,000 msec, effect decreased, 12 4% (p less 0.001) 300 msec. APD95 (by 6 3%) much its faster pacing, 27 12% msec 35 8% shortest 1:1 length. rate-dependent APD qualitatively quantitatively different among species. Human greatest frequency-dependent drug effects on repolarization, followed from dogs rabbits. Guinea pig least (and statistically nonsignificant) APD. Drug-induced refractoriness paralleled those We conclude that: 1) both increase with rate-dependence, 2) enhanced rapid rates typical 3) animal tissues may differ importantly their sensitivity salutary fibrillation be due enhancement characteristic arrhythmia.

参考文章(32)
Leonard S. Gettes, James R. Foster, Ross J. Simpson, Clinical use of antiarrhythmic drugs Springer, Boston, MA. pp. 235- 298 ,(1983) , 10.1007/978-1-4613-3855-0_8
S Nattel, Relationship between use-dependent effects of antiarrhythmic drugs on conduction and Vmax in canine cardiac Purkinje fibers. Journal of Pharmacology and Experimental Therapeutics. ,vol. 241, pp. 282- 288 ,(1987)
H. J. G. M. CRIJNS, L. M. VAN WIJK, W. H. VAN GILST, J. HERRE KINGMA, I. C. VAN GELDER, K. I. LIE, Acute conversion of atrial fibrillation to sinus rhythm: clinical efficacy of flecainide acetate. Comparison of two regimens. European Heart Journal. ,vol. 9, pp. 634- 638 ,(1988) , 10.1093/OXFORDJOURNALS.EURHEARTJ.A062553
Jeffrey L. Anderson, Joan R. Lutz, Scott B. Allison, Electrophysiologic and antiarrhythmic effects of oral flecainide in patients with inducible ventricular tachycardia Journal of the American College of Cardiology. ,vol. 2, pp. 105- 114 ,(1983) , 10.1016/S0735-1097(83)80382-9
Ellison Berns, Robert L. Rinkenberger, Ming K. Jeang, Anne H. Dougherty, Mary Jenkins, Gerald V. Naccarelli, Efficacy and safety of flecainide acetate for atrial tachycardia or fibrillation. American Journal of Cardiology. ,vol. 59, pp. 1337- 1341 ,(1987) , 10.1016/0002-9149(87)90915-5
Andras Varro, Victor Elharrar, Borys Surawicz, Frequency-Dependent Effects of Several Class I Antiarrhythmic Drugs on &OV0312;max of Action Potential Upstroke in Canine Cardiac Purkinje Fibers Journal of Cardiovascular Pharmacology. ,vol. 7, pp. 482- 492 ,(1985) , 10.1097/00005344-198505000-00011
Charles R. Webb, Joel Morganroth, Sheila Senior, Scott R. Spielman, Allan M. Greenspan, Leonard N. Horowitz, Flecainide: steady state electrophysiologic effects in patients with remote myocardial infarction and inducible sustained ventricular arrhythmia Journal of the American College of Cardiology. ,vol. 8, pp. 214- 220 ,(1986) , 10.1016/S0735-1097(86)80115-2
J. -J. Goy, R. Maendly, M. Grbic, L. Finci, U. Sigwart, Cardioversion with flecainide in patients with atrial fibrillation of recent onset European Journal of Clinical Pharmacology. ,vol. 27, pp. 737- 738 ,(1985) , 10.1007/BF00547059
M.R. Boyet, B.R. Jewell, Analysis of the effects of changes in rate and rhythm upon electrical activity in the heart. Progress in Biophysics & Molecular Biology. ,vol. 36, pp. 1- 52 ,(1981) , 10.1016/0079-6107(81)90003-1